Publications

Title

Author

Year

Epidemiologic, immunologic and practical considerations in developing and evaluating a human hookworm vaccine.

BROOKER, S; Bethony, JM; RODRIGUES, LC; ALEXANDER, N; Geiger, SM; Hotez, PJ;

2005

Expert review of vaccines, (2005).4 1 10.1586/14760584.4.1.35.

Bacteremia among children admitted to a rural hospital in Kenya.

Berkley, JA; Lowe, BS; Mwangi, I; Williams, T; Bauni, E; Mwarumba, S; Ngetsa, C; Slack, MP E; Njenga, S; Hart, CA; Maitland, K; English, M; Marsh, K; SCOTT, JA G;

2005

The New England journal of medicine, (2005).352 1 10.1056/NEJMoa040275.

Immunisation at the crossroads: 9th National Immunisation/1st Asia-Pacific Vaccine Preventable Diseases Conference.

McIntyre, PB; Kelly, HA; MULHOLLAND, EK;

2005

The Medical journal of Australia, (2005).182 1

Practical aspects of phase 3 vaccine trials in developing countries.

GREENWOOD, B;

2005

The Grand Challenge for the Future , Birkhauser Verlag (Basel) (2005).

IgG antibodies to merozoite surface antigens are associated with recovery from chloroquine (CQ)-resistant P. falciparum in Gambian children [MIM-CS-62139].

Pinder, M; SUTHERLAND, CJ; Sisay-Joof, F; Ismaili, J; McCall, MB B; Ord, R; Hallett, R; Holder, AA; Milligan, P;

2005

ACTA TROPICA, (2005).95,

Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial.

Gessner, BD; Sutanto, A; Linehan, M; Djelantik, IG G; Fletcher, T; Gerudug, IK; Ingerani,; Mercer, D; Moniaga, V; Moulton, LH; Moulton, LH; MULHOLLAND, K; Nelson, C; Soemohardjo, S; Steinhoff, M; Widjaya, A; Stoeckel, P; Maynard, J; Arjoso, S;

2005

Lancet, (2005).365 9453 10.1016/s0140-6736(04)17664-2.

Genetically engineered structure-based vaccine for bluetongue disease.

ROY, P;

2004

Veterinaria italiana, (2004).40 4

Estimating the force of measles virus infection from hospitalised cases in Lusaka, Zambia.

SCOTT, S; Mossong, J; Moss, WJ; Cutts, FT; Kasolo, F; Sinkala, M; COUSENS, S;

2004

Vaccine, (2004).23 6 10.1016/j.vaccine.2004.07.026.

Risk of myocardial infarction and stroke after acute infection or vaccination.

SMEETH, L; THOMAS, SL; Hall, AJ; Hubbard, R; Farrington, P; Vallance, P;

2004

The New England journal of medicine, (2004).351 25 10.1056/NEJMoa041747.

Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria.

POLLEY, SD; Mwangi, T; Kocken, CH M; Thomas, AW; Dutta, S; Lanar, DE; Remarque, E; Ross, A; Williams, TN; Mwambingu, G; Lowe, B; CONWAY, DJ; Marsh, K;

2004

Vaccine, (2004).23 5 10.1016/j.vaccine.2004.05.031.